#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leiomyosarcoma Fibrosarcoma HER2 gene amplification Pyoderma gangrenosum Metastases to central nervous system Microvillous inclusion disease Neuronal ceroid lipofuscinosis Cryoglobulinaemia Nodal marginal zone B-cell lymphoma Breast angiosarcoma metastatic Von Willebrand's disease Liver transplant rejection Malignant melanoma Cutaneous T-cell lymphoma stage II Alpha-1 antitrypsin deficiency More trials…

    Learn about Rare Diseases

    Ornithine transcarbamoylase deficiency – Diagnostics Systemic sclerosis pulmonary – Life with Disease Burkitt’s lymphoma Tuberous sclerosis complex Friedreich’s ataxia – Basic Information Alternating hemiplegia of childhood – Life with Disease Antisynthetase syndrome – Basic Information Castleman’s disease – Basic Information Sarcoma – Diagnostics Medulloblastoma recurrent – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pravastatin Sodium Ciclesonide Microcrystalline Cellulose Gilteritinib Etavopivat Mesenchymal Cells LIPASE Tocotrienol Disodium Folinate L-Lysine Acetate Cefixime Riboflavin Sodium Phosphate Pbf-999 Polatuzumab Vedotin FRUQUINTINIB Niflumic Acid Alks 2680 SILYMARIN Levoleucovorin Disodium Dnth103 More therapies…

    Learn about Your Condition

    Tourette's disorder Alport's syndrome Osteopenia Epicondylitis Takayasu's arteritis Lymphangioma Chorea Amyotrophic lateral sclerosis Aplastic anaemia Pharyngeal cancer stage I Abortion threatened Urea cycle disorder Hepatic cirrhosis Bladder cancer Pustular psoriasis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study of the safety and effectiveness of REGN17372 and linvoseltamab in adults with relapsed or refractory multiple myeloma

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Linvoseltamab
    • Dexamethasone
    • Diphenhydramine Hydrochloride
    Greece

  • Study evaluating the omission of exemestane, letrozole, anastrozole, and tamoxifen in postmenopausal women with low-risk early breast cancer.

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Tamoxifen
    • Anastrozole
    • Letrozole
    France

  • A study to evaluate the safety and effectiveness of QEL-005 in patients with diffuse cutaneous systemic sclerosis and difficult to treat rheumatoid arthritis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    • Systemic scleroderma
    Germany Spain

  • A study to evaluate the safety and tolerability of azathioprine in patients with autosomal dominant polycystic kidney and liver disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Congenital cystic kidney disease
    Investigated Drugs:
    • Azathioprine
    Belgium

  • A study to evaluate the effect of survodutide on protein levels in the urine for patients with chronic kidney disease

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • BI 456906
    • SURVODUTIDE
    Germany The Netherlands Spain

  • Study evaluating the effects of palopegteriparatide and alfacalcidol on quality of life and brain function in patients with hypoparathyroidism

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypoparathyroidism
    Investigated Drugs:
    • Alfacalcidol
    • Palopegteriparatide
    Denmark
Previous Page
1 … 719 720 721 722 723 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!